YK 11 - Dragon Pharma

YK11, introduced in 2011 by Kanno, is a steroid-based selective androgen receptor modulator. Its distinct structure enables partial stimulation of androgen receptors, promoting muscle development with fewer androgenic outcomes. YK11 also elevates follistatin levels, a protein that counters myostatin's growth-limiting effects. This dual function of receptor interaction and myostatin inhibition has drawn attention for potential use in research and enhancing muscle gains.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about YK 11 by Dragon Pharma, consult with your doctor or healthcare professional.